Barclays PLC Chemo Centryx, Inc. Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2021 Nov 09, 2021	SELL	$13.18 - $19.83 $950,278 - $1.43 Million	-72,100 Reduced 23.75%	231,500 $3.96 Million
Q2 2021 Aug 13, 2021	BUY	$9.59 - $50.88 $1.95 Million - $10.4 Million	203,600 Added 203.6%	303,600 $4.07 Million
Q1 2020 May 13, 2020	BUY	$32.73 - $50.78 $3.27 Million - $5.08 Million	100,000 New	100,000 $4.02 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.